GBLT Corp GBLTF

Conglomerates Electronic Components

GBLT Corp., through its subsidiary, GBT GmbH, designs, manufactures and supplies mobile storage and battery solutions. The Company is also a provider of renewable energy solutions via its solar division, participating in the solar energy market. In addition, the Company offers consumer healthcare and wellness products to retail chains across the globe. It is also an official licensee for AGFAPHOTO mobile energy products. The Company manufactures and distributes a range of mobile energy products worldwide, such as batteries, rechargeable batteries and chargers. The Company’s branded healthcare and wellbeing products are primarily sold throughout Europe under Dr. Senst brand. Through Dr. Senst brand, it offers electronic personal protection equipment (PPE) products, such as fever thermometers, blood pressure oximeters and others. The Company is also the official licensee of Avide / ENTAC light emitting diodes (LED) lighting products.

GREY:GBLTF - Post by User

GBLT Corp > Q3 2020 Announced

<< Previous

Bullboard Posts

Next >>

Post by Wallstreetjackon Nov 30, 2020 10:16am

668 Views

Post# 31999781

Q3 2020 Announced

Highlights below

Revenue for the three months ended September 30, 2020 was €9.7 million compared to €6,6 million for the same period in 2019, an increase of 47%. Revenue for the nine month period ended September 30, 2020 was €19.5 million compared to €14.9 million for the same period in 2019, an increase of 31%.
Gross profit for the three months ended September 30, 2020 was €1.0 million compared to €0.4 million for the same period in 2019, an increase of 173%. Gross profit for the nine month period ended September 30, 2020 was €2.3 million compared to €1.2 million for the same period in 2019, an increase of 95%.
Gross margin for the three months ended September 30, 2020 was 10.0% compared to 5.4% for the same period in 2019. The increase is directly attributable to the introduction and sales of Dr. Senst brand of medical products.
Operating expenses for the three months ended September 30, 2020 totaled €0.4 million compared to €0.4 million for the same period in 2019. Operating expenses for the nine months ended September 30, 2020 totaled €1.3 million compared to €1.3 million for the same period in 2019.
Adjusted EBITDA for the three months ended September 30, 2020 totaled €0.61 million compared to €0.0 million for the same period in 2019. Adjusted EBITDA for the nine months ended September 30 2020 was €1.1 million compared to €0.17 million for the same period in 2019.
Net income for three months ended September 20, 2020 totaled €0.57 million compared to net loss of (€0.06 million) for the same period in 2019. Net income for nine months ended September 30, 2020 was €0.95 million, compared to net loss of (€0.10 million) for the same period in 2019.